Pacer Advisors
ORIC icon

Pacer Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Pacer Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+1,516
New +$13.7K ﹤0.01% 2283
2024
Q3 		– Sell
-661
Closed -$4.67K – 2655
2024
Q2 		$4.67K Buy
661
+145
+28% +$1.3K ﹤0.01% 3643
2024
Q1 		$7.09K Buy
+516
New +$6.13K ﹤0.01% 3577
2021
Q2 		– Sell
-1,572
Closed -$39K – 1507
2021
Q1 		$39K Buy
+1,572
New +$49.7K ﹤0.01% 1466

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pacer Advisors's ORIC Position: Q2 2026 in Review

Pacer Advisors opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 1,516 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2283 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in ORIC as recently as Q2 2024.

Pacer Advisors first reported a position in ORIC in Q1 2021 and has held it in 4 quarters since. The position peaked at $39K in Q1 2021. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Pacer Advisors held 1,516 shares of Oric Pharmaceuticals worth $16K as of Q2 2026.
  • Oric Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2283 holding.
  • Pacer Advisors first reported a position in Oric Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Pacer Advisors's Oric Pharmaceuticals position peaked at $39K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.